Catalyst
Slingshot members are tracking this event:
Phase 1 data of Celyad's (CYAD) CYAD-101 (alloSHRINK) in Colorectal cancer to be presented at ESMO
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CYAD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 05, 2019
Occurred Source:
https://www.celyad.com/en/news/celyad-presents-update-on-autologous-allogeneic-nkg2d-based-car-t-therapies-in-solid-tumors
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cyad-101, Alloshrink, Colorectal Cancer
